Infection researchers from the German Primate Center (DPZ)-- Leibniz Institute for Primate Research have in cooperation with international colleagues tested a new vaccination strategy against the HIV -
related simian immunodeficiency virus (SIV) in rhesus monkeys.
Not exact matches
Researchers for the past decade have focused on the T cell approach, based on studies showing that monkeys receiving such vaccines against
simian immunodeficiency virus,
related to HIV, lived longer or had lower viral levels than usual.
The virus most closely
related to HIV - 1 is a
simian immunodeficiency virus (SIV) thus far identified only in captive members of the chimpanzee subspecies Pan troglodytes troglodytes.